Panacent Bio Inc. — Form D

Panacent Bio Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-12. The offering totals $13, of which $13 was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-07-12
• Form: D
• Accession: 0002030065-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $13
• Amount sold: $13
• Investors: 1
• Date of first sale: 2024-06-25
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-518567

Issuer

• Name: Panacent Bio Inc.
• CIK: 0002030065
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 666 GREENWICH STREET 744, NEW YORK, NY, 10014
• Phone: 415-710-9061

Officers, directors & promoters (3)

More

• CIK 2030065 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search